In order to provide the best possible care and develop new forms of treatment, we should know how the brain functions of infants develop, but no objective and sufficiently precise methods for ...

Due to identifiability concerns, tests concerning the parameters of interest may not be able to use conventional theories and it may not be clear how to assess statistical significance. This paper ...

We look forward to working with MD Anderson to evaluate Precise MRD's utility in cancer care. Our collaborative studies will explore how our ultrasensitive Precise MRD test can enhance treatment ...

The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the clinical evaluation and development of Myriad's ...